Daily Digestive Probiotic
Natural health product licensed in Canada
- Licence holder
- SCI International
- NPN or DIN-HM
- 80085815
- Status
- Active licence
- Licence date
- 1 June 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium animalis subsp. lactis Source : SD-5219 | 25 Millions d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : Cellule entière | 25 Millions d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Cellule entière | 2.9 Milliard d'unités formatrices de colonie par gramme | Not calculated |
| Lactobacillus acidophilus Source : B-3208 | 2.9 Milliard d'unités formatrices de colonie par gramme | Not calculated |
| Bifidobacterium bifidum Source : Cellule entière | 25 Millions d'UFC | Not calculated |
| Bifidobacterium bifidum Source : SD-6576 | 25 Millions d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : Cellule entière | 25 Millions d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : SD-5588 | 25 Millions d'UFC | Not calculated |
| Bifidobacterium longum subsp. infantis Source : Bifidobacterium longum subsp. infantis 6720 | 25 Millions d'UFC | Not calculated |
| Bifidobacterium longum subsp. infantis Source : Cellule entière | 25 Millions d'UFC | Not calculated |
Non-medicinal ingredients
Dioxyde de titane, Gomme de gellane, Stéarate de magnésium, Caséinate de sodium, Citrate de sodium dihydraté, Hypromellose, Gallate de propyle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Source of probiotics. Helps support gastrointestinal health. Could promote a favorable gut flora.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Keep out of the reach of children. if you are pregnant and or breastfeeding, consult a health care practitioner prior to use. If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner.
- Contre-indications
If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product.
Source
Official Health Canada record, licence 80085815
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.